Carregant...
Long-term Response After Stopping Immunotherapy in a Patient With Metastatic Renal Cancer
Background/Aim: Kidney cancers account for about 2% of human malignancies. In recent decades, the incidence of this cancer type has gradually increased, mainly due to advances in imaging. The metastatic potential of these cancers is significant: a quarter of patients will immediately present with me...
Guardat en:
| Publicat a: | In Vivo |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
International Institute of Anticancer Research
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8193289/ https://ncbi.nlm.nih.gov/pubmed/33910866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12441 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|